A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance
Point-of-care (POC) nucleic acid detection technologies are poised to aid gold-standard technologies in controlling the COVID-19 pandemic, yet shortcomings in the capability to perform critically needed complex detection-such as multiplexed detection for viral variant surveillance-may limit their wi...
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert Inc
2023
|
Online Access: | https://hdl.handle.net/1721.1/150365 |
Similar Items
-
Massively multiplexed nucleic acid detection using Cas13
by: Ackerman, Cheri M., et al.
Published: (2020) -
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
by: Kellner, Max J., et al.
Published: (2018) -
Multiplexed detection of bacterial nucleic acids using Cas13 in droplet microarrays
by: Thakku, Sri Gowtham, et al.
Published: (2023) -
Multiplex targeted mass spectrometry assay for one-shot flavivirus diagnosis
by: Wee, Sheena, et al.
Published: (2021) -
Infection, immunity, and surveillance of COVID-19
by: Suthar, AB, et al.
Published: (2022)